Clinical trial
Effects of Celecoxib After Percutaneous Coronary Intervention
NCT00292721 · Seoul National University Hospital, Other · Completed
Key facts
| NCT number | NCT00292721 |
|---|---|
| Title | Effects of Celecoxib After Percutaneous Coronary Intervention |
| Official title | Effects of Celecoxib on Restenosis After Percutaneous Coronary Intervention and Evolution of Atherosclerosis (COREA) Trial |
| Lead sponsor | Seoul National University Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Arteriosclerosis |
| Intervention type | Drug |
| Interventions | Celecoxib |
| Enrollment | 260 |
| Start date | Aug 1, 2004 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Feb 16, 2006 |
| Last update posted | Jul 21, 2011 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: